Answers are grounded in this paper and cite their sources.
An assessment of the risk of new cancers in patients with Hodgkin's disease (HD) requires consideration of potential intrinsic and extrinsic factors. Because series of untreated patients with HD do not exist, the true intrinsic risk of development of new cancers cannot be assessed, although the immunologic abnormalities associated with active HD are a potential contributory factor. In recent years, reports of new cancers occurring in patients with HD have considered the role of extrinsic factors in the form of therapeutic intervention. Exposure to ionizing radiation, a known carcinogen in humans, has been suggested as a possible explanation of increasing reports of cases of acute nonlymphocytic leukemia (ANLL) complicating HD. Studies from the National Cancer Institute have shown a highly significant increase in incidence of new cancers (including ANLL) in intensively treated HD patients, and suggested the possibility of a synergistic carcinogenic effect of combined exposure to ionizing radiation and cytotoxic drugs. While the mechanism of induction of second malignant tumors in patients with HD is not clear, it is probably complex, and may relate to interactions between immunosuppressive factors associated with the disease and further immunosuppression and direct cellular damage produced by radiation, cytotoxic drugs, or combinations of both. Further efforts to investigate long term complications of cancer therapy and to design therapeutic programs that will minimize these complications are most important, in view of the improved survival in a number of malignant diseases, which may be anticipated with modern multimodal anticancer therapy.
No takes yet. Share an insight, caveat, or question.
Arseneau et al. (1977) studied this question.
Synapse has enriched 10 related papers. Consider them for comparative context: